Mycenax Biotech Inc
TPEX:4726
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mycenax Biotech Inc
TPEX:4726
|
TW |
|
MilDef Group AB
STO:MILDEF
|
SE |
|
Busan Industrial Co Ltd
KRX:011390
|
KR |
|
Banco Bilbao Vizcaya Argentaria SA
OTC:BBVXF
|
ES |
|
E
|
Empresas Copec SA
SGO:COPEC
|
CL |
|
O
|
Omnia Holdings Ltd
SWB:OHZ
|
ZA |
|
I
|
Industria de Diseno Textil SA
WSE:ITX
|
ES |
|
Presidio Production Co
NYSE:FTW
|
US |
|
O
|
OHTL PCL
SET:OHTL
|
TH |
|
M
|
Mondi PLC
OTC:MNODF
|
UK |
|
STRABAG SE
VSE:STR
|
AT |
|
Semba Corp
TSE:6540
|
JP |
|
A-Zenith Home Furnishings Co Ltd
SSE:603389
|
CN |
|
Berkeley Group Holdings PLC
LSE:BKG
|
UK |
|
P
|
Pfizer Inc
XHAM:PFE
|
US |
|
Arvind Ltd
BSE:500101
|
IN |
|
S
|
SLB NV
XHAM:SCL
|
US |
Bankruptcy Probability
Mycenax Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mycenax Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
M
|
Mycenax Biotech Inc
TPEX:4726
|
4.8B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mycenax Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mycenax Biotech Inc has total debt of 888.9m TWD. This includes both short-term (450m TWD) and long-term (438.9m TWD) debt.
You can find a full breakdown on its Balance Sheet.